Samuel12_1980

Samuel12_1980

Bearish or bullish?

Samuel12_1980

Interesting Level. Holing from today Very risky stock, so not for any suggestion!

Samuel12_1980

KALA focused on the development and commercialization of therapeutics using proprietary AMPPLIFY mucus-penetrating particle, or MPP, drug delivery technology, with an initial focus on the treatment of eye diseases INVELTYS - approved by FDA on August 22, 2018. US launch in January 2019 KPI121 0.25% - on PH3 (Third trail on-going), Top line results expected in Q4...

Samuel12_1980

Looks like long

Samuel12_1980

Top Line results from Phase 2 study in pancreatic cancer (With MDACC) - 1H 2019 Technical overview - above MA20

Samuel12_1980

(3 MA support, 1 left)

Samuel12_1980

In today. Stop 3.8

Samuel12_1980

Welcome to Disneyland Above 1.35 is great :)

Samuel12_1980

weekly bearish with SHS

Samuel12_1980

2 scenario 1. Short term - Bearish as shown 2. Weekly - Bullish with SHS Support at 0.92 in case of bearish. Lets see

Samuel12_1980

Now above MA50 Don't forget, very risky :)

Samuel12_1980

Oscillators on the ground. Support should be at 10.12 (Hopefully). Case I'm right, Level C should be next on that downtrend line. Back to normal\Long, not before 12.3

Samuel12_1980

Is she can fight? fight that Liver cancer? Technical, Not yet there for good signs... 1.17 .....1.23-1.24 (MA200) I'm in and taking that risks Good-luck to holders and CANF

Samuel12_1980

Good signs only above F50% (51.53~) Destination 56~ Tight stop!

Samuel12_1980

Thx and good luck to all I'm done.

Samuel12_1980

A better look Good signs only above 1.23-1.25, then 1.35 going to be very stressful weeks

Samuel12_1980

In case closing above 1.35 , target is 1.52 or MA200 (1.65)

Samuel12_1980

Namodenoson (CF102) Cancer - advanced liver cancer phase 2 results in Q1 2019 (in few weeks) Very risky